Management of Women with Recurrent Pregnancy Losses and Antiphospholipid Antibody Syndrome

Joanne Kwak-Kim, Maria Socorro L Agcaoili, Lara Aleta, Aihua Liao, Kuniaki Ota, Svetlana Dambaeva, Kenneth Beaman, Joon Woo Kim, Alice Gilman-Sachs

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Antiphospholipid antibodies (aPL) have been associated with recurrent pregnancy losses (RPL) and other obstetrical complications. The diagnostic criteria for the classical antiphospholipid antibody syndrome (APS) have been utilized for the detection of obstetrical APS in women with RPL. However, laboratory findings and immunopathology of obstetrical APS are significantly different from those of classical APS. In addition, many women with RPL who have positive aPL do not have symptoms consistent with the current APS criteria. The induction of a proinflammatory immune response from trophoblasts and complement activation by aPL rather than thromboembolic changes has been reported as a major immunopathological feature of obstetrical APS. Heparin treatment has been reported to be effective in prevention of early pregnancy loss with APS but not for the late pregnancy loss or complications. The complex effects of heparin may explain the limited efficacy of heparin treatment in RPL. New diagnostic criteria for obstetrical APS are needed urgently, and new therapeutic approaches should be explored further.

Original languageEnglish
Pages (from-to)596-607
Number of pages12
JournalAmerican Journal of Reproductive Immunology
Volume69
Issue number6
DOIs
Publication statusPublished - 2013 Jun

Fingerprint

Antiphospholipid Syndrome
Pregnancy
Antiphospholipid Antibodies
Heparin
Complement Activation
Trophoblasts
Therapeutics

Keywords

  • Heparin treatment
  • Immunoglobulin G
  • Implantation
  • Inflammation
  • Obstetrical complications
  • Trophoblast

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Kwak-Kim, J., Agcaoili, M. S. L., Aleta, L., Liao, A., Ota, K., Dambaeva, S., ... Gilman-Sachs, A. (2013). Management of Women with Recurrent Pregnancy Losses and Antiphospholipid Antibody Syndrome. American Journal of Reproductive Immunology, 69(6), 596-607. https://doi.org/10.1111/aji.12114

Management of Women with Recurrent Pregnancy Losses and Antiphospholipid Antibody Syndrome. / Kwak-Kim, Joanne; Agcaoili, Maria Socorro L; Aleta, Lara; Liao, Aihua; Ota, Kuniaki; Dambaeva, Svetlana; Beaman, Kenneth; Kim, Joon Woo; Gilman-Sachs, Alice.

In: American Journal of Reproductive Immunology, Vol. 69, No. 6, 06.2013, p. 596-607.

Research output: Contribution to journalArticle

Kwak-Kim, J, Agcaoili, MSL, Aleta, L, Liao, A, Ota, K, Dambaeva, S, Beaman, K, Kim, JW & Gilman-Sachs, A 2013, 'Management of Women with Recurrent Pregnancy Losses and Antiphospholipid Antibody Syndrome', American Journal of Reproductive Immunology, vol. 69, no. 6, pp. 596-607. https://doi.org/10.1111/aji.12114
Kwak-Kim, Joanne ; Agcaoili, Maria Socorro L ; Aleta, Lara ; Liao, Aihua ; Ota, Kuniaki ; Dambaeva, Svetlana ; Beaman, Kenneth ; Kim, Joon Woo ; Gilman-Sachs, Alice. / Management of Women with Recurrent Pregnancy Losses and Antiphospholipid Antibody Syndrome. In: American Journal of Reproductive Immunology. 2013 ; Vol. 69, No. 6. pp. 596-607.
@article{d3c7df311b6f4edfbf8c1b63be5abfe7,
title = "Management of Women with Recurrent Pregnancy Losses and Antiphospholipid Antibody Syndrome",
abstract = "Antiphospholipid antibodies (aPL) have been associated with recurrent pregnancy losses (RPL) and other obstetrical complications. The diagnostic criteria for the classical antiphospholipid antibody syndrome (APS) have been utilized for the detection of obstetrical APS in women with RPL. However, laboratory findings and immunopathology of obstetrical APS are significantly different from those of classical APS. In addition, many women with RPL who have positive aPL do not have symptoms consistent with the current APS criteria. The induction of a proinflammatory immune response from trophoblasts and complement activation by aPL rather than thromboembolic changes has been reported as a major immunopathological feature of obstetrical APS. Heparin treatment has been reported to be effective in prevention of early pregnancy loss with APS but not for the late pregnancy loss or complications. The complex effects of heparin may explain the limited efficacy of heparin treatment in RPL. New diagnostic criteria for obstetrical APS are needed urgently, and new therapeutic approaches should be explored further.",
keywords = "Heparin treatment, Immunoglobulin G, Implantation, Inflammation, Obstetrical complications, Trophoblast",
author = "Joanne Kwak-Kim and Agcaoili, {Maria Socorro L} and Lara Aleta and Aihua Liao and Kuniaki Ota and Svetlana Dambaeva and Kenneth Beaman and Kim, {Joon Woo} and Alice Gilman-Sachs",
year = "2013",
month = "6",
doi = "10.1111/aji.12114",
language = "English",
volume = "69",
pages = "596--607",
journal = "American Journal of Reproductive Immunology and Microbiology",
issn = "8755-8920",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Management of Women with Recurrent Pregnancy Losses and Antiphospholipid Antibody Syndrome

AU - Kwak-Kim, Joanne

AU - Agcaoili, Maria Socorro L

AU - Aleta, Lara

AU - Liao, Aihua

AU - Ota, Kuniaki

AU - Dambaeva, Svetlana

AU - Beaman, Kenneth

AU - Kim, Joon Woo

AU - Gilman-Sachs, Alice

PY - 2013/6

Y1 - 2013/6

N2 - Antiphospholipid antibodies (aPL) have been associated with recurrent pregnancy losses (RPL) and other obstetrical complications. The diagnostic criteria for the classical antiphospholipid antibody syndrome (APS) have been utilized for the detection of obstetrical APS in women with RPL. However, laboratory findings and immunopathology of obstetrical APS are significantly different from those of classical APS. In addition, many women with RPL who have positive aPL do not have symptoms consistent with the current APS criteria. The induction of a proinflammatory immune response from trophoblasts and complement activation by aPL rather than thromboembolic changes has been reported as a major immunopathological feature of obstetrical APS. Heparin treatment has been reported to be effective in prevention of early pregnancy loss with APS but not for the late pregnancy loss or complications. The complex effects of heparin may explain the limited efficacy of heparin treatment in RPL. New diagnostic criteria for obstetrical APS are needed urgently, and new therapeutic approaches should be explored further.

AB - Antiphospholipid antibodies (aPL) have been associated with recurrent pregnancy losses (RPL) and other obstetrical complications. The diagnostic criteria for the classical antiphospholipid antibody syndrome (APS) have been utilized for the detection of obstetrical APS in women with RPL. However, laboratory findings and immunopathology of obstetrical APS are significantly different from those of classical APS. In addition, many women with RPL who have positive aPL do not have symptoms consistent with the current APS criteria. The induction of a proinflammatory immune response from trophoblasts and complement activation by aPL rather than thromboembolic changes has been reported as a major immunopathological feature of obstetrical APS. Heparin treatment has been reported to be effective in prevention of early pregnancy loss with APS but not for the late pregnancy loss or complications. The complex effects of heparin may explain the limited efficacy of heparin treatment in RPL. New diagnostic criteria for obstetrical APS are needed urgently, and new therapeutic approaches should be explored further.

KW - Heparin treatment

KW - Immunoglobulin G

KW - Implantation

KW - Inflammation

KW - Obstetrical complications

KW - Trophoblast

UR - http://www.scopus.com/inward/record.url?scp=84877700397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877700397&partnerID=8YFLogxK

U2 - 10.1111/aji.12114

DO - 10.1111/aji.12114

M3 - Article

VL - 69

SP - 596

EP - 607

JO - American Journal of Reproductive Immunology and Microbiology

JF - American Journal of Reproductive Immunology and Microbiology

SN - 8755-8920

IS - 6

ER -